Caxias do Sul, Brazil--Men over the age of 40 years may have lower semen quality, but not necessarily lower sperm morphology. That's an important fact to remember when evaluating these men for infertility, suggests a study by Brazilian researchers.
Published data show superiority of cefepime–taniborbactam over meropenem for cUTI
Cefepime-taniborbactam is currently under review by the FDA for cUTI, including acute pyelonephritis, based on data from the CERTAIN-1 trial.
Dr. Malik evaluates quality of Reddit content on recurrent UTIs
“I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
Oral sulopenem shows superiority to amoxicillin/clavulanate for uUTIs
Iterum plans to resubmit a New Drug Application for oral sulopenem for the treatment of patients with uUTi in Q2 of 2024.
Destigmatizing Urology: Dr. Blaivas discusses vaginal mesh surgery
“To me, the overwhelming thing is understanding that treatments are, by and large, effective,” says Jerry G. Blaivas, MD, FACS.
American Urogynecologic Society (AUGS) Coding Webinar Series
There are several new CPT codes for 2024, including Category III codes for tibial nerve stimulation and other changes to codes in the treatment of urinary incontinence.
FDA grants NRX-101 Fast Track and QIDP designations for complicated UTI and pyelonephritis
NRX-101 is a fixed-dose combination of the broad-spectrum antibiotic D-cycloserine and lurasidone.
2 Commerce Drive Cranbury, NJ 08512